மோசடி நிகர News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from மோசடி நிகர. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In மோசடி நிகர Today - Breaking & Trending Today
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Longeveron Inc. Announces the Appointment of Prominent Biotech, Capital Markets and Corporate . LongeveronFebruary 18, 2021 GMT MIAMI, Feb. 18, 2021 (GLOBE NEWSWIRE) Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced the appointments of Douglas Losordo, M.D., Erin Borger, and Cathy Ross to the Company’s Board of Directors. Douglas Losordo, MD Dr. Losordo has worked in the biotech industry for over twenty years, most recently serving as Executive Vice President, Head of Research and Development and Chief Medical Officer of KBP Biosciences Inc. Dr. Losordo was previously the Executive Vice President, Global Head of Research and Development, Chief Medical Officer of Caladrius Biosciences (Nasdaq: CLBS), a ....
Longeveron Inc. Announces the Appointment of Prominent Biotech, Capital Markets and Corporate Finance Executives to the Board of Directors February 18, 2021 08:30 ET | Source: Longeveron Longeveron MIAMI, Feb. 18, 2021 (GLOBE NEWSWIRE) Longeveron Inc. (NASDAQ: LGVN) ( Longeveron or Company ), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced the appointments of Douglas Losordo, M.D., Erin Borger, and Cathy Ross to the Company’s Board of Directors. Douglas Losordo, MD Dr. Losordo has worked in the biotech industry for over twenty years, most recently serving as Executive Vice President, Head of Research and Development and Chief Medical Officer of KBP Biosciences Inc. Dr. Losordo was previously the Executive Vice President, Global Head of Research and Development, Chief Medical Officer of Caladrius Biosciences (Nasdaq: CL ....